SCHEDULE 13D (SF)

Company

BIOXYTRAN, INC

Filed

June 15, 2020

Accession Number

0001785982-20-000543

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →